Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
JIM CRAMER
'Mad Money' Lightning Round: Oracle, Zillow, Pfizer and more
By Scott Rutt
Mar 3, 2021 8:02 AM EST
PRESS RELEASES
U.S. FDA Expands Approval Of Pfizer's LORBRENA® As First-Line Treatment For ALK-Positive Metastatic Lung Cancer
By Business Wire
Mar 3, 2021 7:03 PM EST
JIM CRAMER
'Mad Money' Lightning Round: Oracle, Zillow, Pfizer and more
By Scott Rutt
Mar 3, 2021 8:02 AM EST
JIM CRAMER
All About Optimism: Cramer's 'Mad Money' Recap (Tuesday 3/2/21)
By Scott Rutt
Mar 2, 2021 8:48 PM EST
PRESS RELEASES
Strata Oncology Announces The Strata PATH Trial With Pfizer As First Pharma Partner
By PR Newswire
Mar 2, 2021 7:00 AM EST
INVESTING
Johnson & Johnson Shares Leap After FDA, CDC Coronavirus Vaccine Approvals
By Martin Baccardax
Mar 1, 2021 9:54 AM EST
INVESTING
Dow Futures Surge as Bond Yields Retreat, Vaccine Pace Accelerates; Johnson & Johnson Gets FDA Approval
By Martin Baccardax
Mar 1, 2021 7:47 AM EST
LATEST NEWS
CDC Committee OK's Johnson & Johnson COVID Shot
By Adam Smith
Feb 28, 2021 5:07 PM EST
LATEST NEWS
As the FDA Takes Center Stage During COVID, Big Changes Could Be Ahead
By Adam Smith
Feb 28, 2021 3:14 PM EST
INVESTING
Jim Cramer: What History Tells Us About Bond-Rate Scares Like This
By Jim Cramer
Mar 1, 2021 7:43 AM EST
LATEST NEWS
Quickly Vaccinating Hong Kong May Be a Long Shot
By Adam Smith
Feb 28, 2021 3:25 PM EST
INVESTING
Johnson & Johnson's COVID-19 Vaccine Is Cleared by the FDA
By Joseph Woelfel
Feb 27, 2021 7:34 PM EST
INVESTING
Johnson & Johnson One-Shot Vaccine Wins Advisory Panel OK
By Tom Bemis
Feb 26, 2021 5:59 PM EST
INVESTING
J&J Vaccine May Be Near OK, With Shots to Follow Soon After
By Dan Weil
Feb 26, 2021 10:14 AM EST
INVESTING
Moderna Extends Gains as Jim Cramer Talks About Potential Cancer Vaccine
By Martin Baccardax
Feb 26, 2021 9:45 AM EST
PRESS RELEASES
European Medicines Agency Accepts Pfizer's Marketing Authorization Application For Its Investigational 20-valent Pneumococcal Conjugate Vaccine For Adults 18 Years Of Age Or Older
By Business Wire
Feb 26, 2021 6:45 AM EST
PRESS RELEASES
EMA Accepts Marketing Application For Somatrogon To Treat Pediatric Patients With Growth Hormone Deficiency
By Business Wire
Feb 26, 2021 6:30 AM EST
Video
Moderna Says Trials for COVID Variant Boost Shot Have Begun
Feb 25, 2021 11:16 AM EST
INVESTING
Moderna Fourth-Quarter Sales Boosted by COVID Vaccine Rollout
By M. Corey Goldman
Feb 25, 2021 11:17 AM EST
PRESS RELEASES
Pfizer And BioNTech Initiate A Study As Part Of Broad Development Plan To Evaluate COVID-19 Booster And New Vaccine Variants
By GlobeNewswire
Feb 25, 2021 6:45 AM EST
PRESS RELEASES
Pfizer And BioNTech Initiate A Study As Part Of Broad Development Plan To Evaluate COVID-19 Booster And New Vaccine Variants
By Business Wire
Feb 25, 2021 6:45 AM EST
MARKETS
Nvidia, GameStop, AMC, Salesforce, Pfizer - 5 Things You Must Know Thursday
By Joseph Woelfel
Feb 25, 2021 8:51 AM EST
INVESTING
Johnson & Johnson COVID Vaccine Gets FDA Support Before Emergency Use Hearing
By Martin Baccardax
Feb 24, 2021 9:33 AM EST
PRESS RELEASES
Seven Bridges Selected By Pfizer To Support Data Management Solution For Single-Cell RNA Sequencing Data
By PR Newswire
Feb 24, 2021 8:00 AM EST
PRESS RELEASES
U.S. FDA Accepts For Priority Review Pfizer's Application For TicoVac™ (Tick-borne Encephalitis Vaccine)
By Business Wire
Feb 23, 2021 4:30 PM EST
